pharmaphorum

DECEMBER 21, 2021

GlaxoSmithKline’ majority-owned HIV unit ViiV has scored a key FDA approval, getting approval for its long-acting drug cabotegravir as the first injectable for pre-exposure prophylaxis (PrEP) –challenging market leader Gilead Sciences. The post FDA okays ViiV’s Apretude as first injectable for HIV PrEP appeared first on.

52

52

Pharmacy Times

JULY 10, 2023

Despite an increase in HIV and poorer clinical outcomes among migrant populations, the uptake of PrEP among these individuals has been understudied.

26

26

Amber

AUGUST 11, 2022

No matter the specialty, clinic size, or type of health system, both roles are susceptible. Get the Most Out of Your Commute Whether you’re stuck in traffic or have a quick drive to the clinic, there are multiple ways you can get the most out of those extra minutes. Before you start prepping, invest in good food storage containers.

Specialty Pharmacies 52

Specialty Pharmacies Medical Schools Hospitals 52

pharmaphorum

JANUARY 11, 2022

Meanwhile, Moderna CEO Stéphane Bancel told CNBC it is currently working on an Omicron-specific shot that is about to start clinical testing and could be available in the autumn. The post Pfizer, Moderna are prepping new vaccines for Omicron appeared first on.

Vaccines 125

Vaccines 125

pharmaphorum

MAY 19, 2022

On HIV Vaccine Awareness Day, we want to acknowledge and thank the scientists, clinical trial participants, volunteers and so many others around the globe working together to advance the hope of a preventive #HIV #vaccine. The post Moderna’s HIV vaccine prepped for trials in Africa appeared first on.

Vaccines 145

Vaccines Immunity Immunization 145

Board Vitals - Pharmacist

DECEMBER 8, 2023

One way to kickstart your exam prep is by reading. Stahl: Renowned for its comprehensive exploration of psychopharmacology, this guide provides in-depth coverage of mechanisms of action, clinical applications, and side effects of psychotropic medications. Valuable for both exam preparation and enhancing clinical skills.

Compounding 52

Compounding Communication Hospitals 52

Board Vitals - Pharmacist

JANUARY 24, 2024

These statistics provide some extra insight on just how difficult the ABIM board exams are, and the importance of adequate exam prep. Success in the exams is contingent on a comprehensive understanding of the material, critical thinking skills, and the ability to apply knowledge in diverse clinical scenarios. Don’t become complacent.

101

101

Putting Patients First Blog

MARCH 11, 2024

It was not until 1993, and after many protests , that the CDC revised the definition of HIV/AIDS to include women, thus allowing them to be included in clinical trials and testing for treatment. In 1988, HIV/AIDS was the eighth leading cause of death among women of reproductive age. million people in the U.S.

Immunity 59

Immunity Immunization 59

Pharmaceutical Technology

DECEMBER 23, 2022

This approval is backed by findings from the multicentre, double-blinded, placebo-controlled, international Phase II/III CAPELLA clinical trial of lenacapavir plus an optimised background regimen. The treatment is indicated for adult patients who are heavily treatment-experienced (HTE) with multi-drug resistant (MDR) HIV-1 infection.

59

59

pharmaphorum

DECEMBER 7, 2021

The two studies – IMPOWER 22 and IMPOWER 24 – are testing islatravir as a once-monthly, oral therapy for pre-exposure prophylaxis or PrEP, which accounts for a sizeable segment of the HIV drugs market.

52

52

pharmaphorum

JUNE 21, 2022

In the study, eplontersen achieved statistically significant and clinically meaningful reductions in serum TTR concentration, indicating that production of the protein had been reduced, and showed evidence of improved neuropathy symptoms versus placebo after 35 weeks.

109

109

Board Vitals - Pharmacist

NOVEMBER 6, 2023

To help you start on your exam prep, we’ve compiled a list of the top 10 psychiatry books. It delves into the mechanisms of action, clinical applications, and side effects of psychotropic medications, making it an essential resource for understanding the pharmacological aspects of psychiatry. Taylor, Thomas R.

Compounding 52

Compounding Communication Hospitals 52

pharmaphorum

SEPTEMBER 28, 2022

Clinical trial results reported at this year’s European Haematology Association (EHA) congress showed that a one-time treatment with exa-cel had a significant benefit in both SCD and thalassaemia patients. The post Vertex, CRISPR prep filing for gene-editing blood disorder therapy appeared first on.

Chemotherapy 57

Chemotherapy Drug Development 57

pharmaphorum

NOVEMBER 20, 2020

The companies said they had already built up expertise after delivering the vaccine to more than 150 clinical trial sites across the US, as well as Europe, Latin America, and South Africa. The post Pfizer/BioNTech prep US COVID-19 vaccine launch after emergency filing appeared first on.

Vaccines 96

Vaccines Documentation 96

Board Vitals - Pharmacist

SEPTEMBER 3, 2022

The specifics of the renewal requirements for nurse practitioners, (and ANCC Certified Clinical Nurse Specialists), according to the ANCC are as follows: 1. The pharmacology requirements may be rigorous, but the right prep courses will prepare you for the renewal certification exam.

Controlled Substances 52

Controlled Substances 52

pharmaphorum

APRIL 14, 2022

Other companies are developing CD3xCD20 bispecifics as well, including Roche’s mosunetuzumab and CD20-TCB and Regeneron’s REGN5678, which are already in clinical trials, although AbbVie is thought to be closest to market. The post AbbVie preps filings for lymphoma bispecific licensed from Genmab appeared first on.

Immunity 62

Immunity Immunization 62

European Pharmaceutical Review

MARCH 11, 2024

Self-stigma is also prevalent and hinders individuals from getting tested, starting pre‑exposure prophylaxis (PrEP) (if they’re HIV negative), seeking the lifesaving treatments they need (if they’re HIV positive), and can lead to isolation and depression. Having clinical trial designs focused on diversity is important.

Immunity 94

Immunity Immunization Clinical Pharmacology Drug Development 94

pharmaphorum

FEBRUARY 21, 2022

The study found that 24% of patients treated with mirikizumab were in clinical remission at 12 weeks – meaning inflammation of the colon is controlled or resolved – compared to 13% of the placebo group. The post Lilly unveils mirikizumab data in ulcerative colitis as it preps filings appeared first on.

Biosimilars 57

Biosimilars 57

pharmaphorum

AUGUST 30, 2022

Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared with placebo, backing up its safety, and according to the investigators the study was not large enough to detect a clinically meaningful reduction in cardiovascular events.

Compounding 98

Compounding 98

pharmaphorum

SEPTEMBER 24, 2020

The app’s ability to predict autism was compared to the usual clinical evaluation process by specialists, and according to Cognoa “surpassed all FDA targets” in the study. The post Cognoa preps FDA filing for digital autism diagnostic appeared first on. Photo by natsuki on Unsplash.

134

134

pharmaphorum

NOVEMBER 3, 2022

The studies involved more than 3,000 female adults and adolescents with uncompleted UTIs and showed that a five-day oral course of gepotidacin was as effective as standard therapy nitrofurantoin at achieving combined clinical and microbiological responses to the infection at 28 days.

98

98

Board Vitals - Pharmacist

JANUARY 4, 2024

We’re sure you are, but we wanted to offer a little extra help as you spend your time prepping. Consultative co‐management 15% Quality, safety, and clinical reasoning 15% The BoardVitals Hospital Medicine MOC question bank consists of over 1,300 hospital medicine board review questions complete with detailed explanations.

Hospitals 52

Hospitals Inpatient 52

pharmaphorum

SEPTEMBER 27, 2021

Lead investigator Dr Craig McDonald of UC Davis said that those improvements were clinically meaningful, and would mean for example that patients would take longer to lose hand-to-mouth function – which is critical to quality of life in non-ambulatory DMD.

Immunity 93

Immunity Immunization 93

pharmaphorum

NOVEMBER 8, 2022

Lilly said it will conduct a phased rollout for the platform to an initial group of clinics caring for type 1 and 2 diabetics starting later this year, with the objective to make it available across the US in 2023. The post Lilly preps for rollout of its connected diabetes system appeared first on.

Diabetes 62

Diabetes Communication 62

pharmaphorum

FEBRUARY 10, 2022

AstraZeneca confirmed today that it has discontinued clinical development of a follow-up to its COVID-19 vaccine Vaxzevria targeted at the Beta variant of the virus, which started development before the emergence of the Delta and Omicron strains.

Vaccines 52

Vaccines Immunity Immunization Diabetes 52

pharmaphorum

JUNE 28, 2022

Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to the US market – 13 years after its first attempt was turned down – thanks to a new phase 3 clinical trial. The post Basilea preps key US filing for MRSA antibiotic ceftobiprole appeared first on.

Hospitals 52

Hospitals 52

Board Vitals - Pharmacist

JANUARY 2, 2024

Understanding the SPEX Exam The SPEX is a comprehensive exam designed to assess your knowledge of basic medical sciences, clinical judgment, and decision-making skills. Choose BoardVitals for Your SPEX Exam Prep The BoardVitals SPEX question bank is a powerful tool for SPEX preparation.

52

52

pharmaphorum

FEBRUARY 4, 2022

Zilucoplan achieved a significant improvement in the Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) total score compared to placebo at week 12 in the RAISE trial, which UCB said was a “clinically meaningful” result. The post UCB preps filings for another challenger to AZ’s Soliris appeared first on.

52

52

pharmaphorum

SEPTEMBER 16, 2021

Just a few months ago, Amylyx was talking about having to complete another clinical trial before it could file for FDA approval of its drug for neurodegenerative disease amyotrophic lateral sclerosis (ALS). The post Amylyx preps filing for its ALS drug after FDA feedback appeared first on.

52

52

pharmaphorum

JUNE 23, 2021

It is also eyeing £2 billion plus in sales for HIV pre-exposure prophylaxis (PrEP) drug Cabenuva (cabotegravir), hepatitis B virus (HBV) antisense drug GSK3228836, and Zejula (niraparib), the PARP inhibitor it acquired as part of its $5.1 billion takeover of Tesaro in 2019. £1

Vaccines 99

Vaccines 99

pharmaphorum

OCTOBER 16, 2020

There are already three other RNA-based vaccines in trials for COVID-19 from Moderna, Pfizer/BioNTech and CureVac, out of 42 candidates in clinical development, according to the World Health Organization’s latest update. The post Sanofi preps trials of second COVID-19 shot, as Russia approves another appeared first on.

Vaccines 98

Vaccines 98

European Pharmaceutical Review

JANUARY 10, 2023

Positive data have emerged from early-phase trials, with clinical benefit to patients irrespective of their PIK3CA/AKT1/PTEN mutational status. It is also being investigated to treat HIV and for pre-exposure prophylaxis (PrEP). Several Phase III trials are now underway.   .

Drug Development 91

Drug Development Diabetes 91

pharmaphorum

OCTOBER 20, 2021

“In the clinical development programmes, zuranolone has shown remarkably consistent, rapid, and sustained reductions in depressive symptoms, including anxiety and sleep loss, in addition to a well-tolerated safety profile,” he added. The post Biogen, Sage prep 2022 filing for depression drug zuranolone appeared first on.

Packaging 52

Packaging 52

pharmaphorum

FEBRUARY 2, 2022

GSK was focusing mainly on developing nemiralisib for chronic obstructive pulmonary disease but had a clinical programme on the go in APDS. The post Pharming preps filing for rare disease drug leniolisib after trial win appeared first on.

Immunity 52

Immunity Immunization Labelling 52

Board Vitals - Pharmacist

OCTOBER 1, 2022

These healthcare professionals can be found in a number of settings, including hospitals and specialty clinics. Our Pediatrics question bank contains more than 1,750 board prep questions formatted to the exam content outline for the American Board of Pediatrics (ABP) General Pediatrics Certifying Exam and the General Pediatrics ITE exam.

Medical Schools 52

Medical Schools Hospitals 52

Board Vitals - Pharmacist

OCTOBER 1, 2022

These healthcare professionals can be found in a number of settings, including hospitals and specialty clinics. Our Pediatrics question bank contains more than 1,750 board prep questions formatted to the exam content outline for the American Board of Pediatrics (ABP) General Pediatrics Certifying Exam and the General Pediatrics ITE exam.

Medical Schools 52

Medical Schools Hospitals 52

pharmaphorum

AUGUST 12, 2020

If approved, olorofim could be the first drug in a new antifungal class in almost two decades, according to Novo Ventures, and “represents a very significant market opportunity in excess of $6 billion, in an area of high unmet clinical need.”. The post Novo-backed $61m fundraising helps F2G prep for antifungal launch appeared first on.

Drug Development 52

Drug Development 52